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Remote areas like Greenland face unique challenges in ensuring 
availability and accessibility of healthcare services (Pong & Pitblado, 
2002; Sibley & Weiner, 2011; Wilson & Rosenberg, 2002), and de-
livery of palliative cancer care is no exception (Wilson et al., 2006). 
Greenland has a total area of over 2 million km2, and about 80% of the 
island is covered by permanent ice. The population is about 56,000 
and lives scattered along the coastline. Most are Inuit, and only 10% 
have been born outside of Greenland (Statistics Greenland, 2016). In 
2013, 105 patients died of cancer, which is a leading cause of death 
in Greenland (The National Board of Health G, 2014). Cancer inci-
dence in 2012 was 164, with a rate of 289 per 100,000 inhabitants 
(The National Board of Health, 2013). The Greenlandic lifestyle has 
been changing rapidly, and the increasing incidence of cancer ap-
pears to be related to demographic, geographic, socio- economic and 
environmental factors (Petersen & Bjerregaard, 2014). Indigenous 
people in the Arctic region have increasing incidence of cancer, and 
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A prospective national cohort study assessed the development of health- related 
quality of life (HRQoL) and symptoms in adult patients undergoing treatment and 
care for advanced cancer in Greenland. HRQol was examined by EORTC QLQ- C30 
version 3.0 questionnaire monthly for 4 months. Changes over time and between- 
group comparisons were examined. Of 58 patients included in the study, 47% com-
pleted the questionnaire four times. Functioning was generally high, and improved 
social functioning was observed after 1 and 2 months. The highest symptom score 
was for fatigue followed by pain and nausea/vomiting. A high score for financial 
problems remained unchanged during the entire period. Patients with higher income 
had reduced pain intensity (p = .03) and diarrhoea (p = .05) than patients with income 
below the poverty line. After 1 month, reduction in pain intensity was observed for 
Nuuk citizens compared with non- Nuuk citizens (p = .05). After 2 months, non- Nuuk 
citizens reported improved social functioning compared with Nuuk citizens (p = .05). 
After 3 months, Global Health in Nuuk citizens was improved compared with non- 
Nuuk citizens (p = .05). An important clinical finding was that patients’ needs for sup-
port are related to social status, and geographical factors should be taken into 
account when planning palliative care.
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their risk is higher than the world average for lung or colorectal can-
cer (Young, Kelly, Friborg, Soininen, & Wong, 2016).
Greenland is part of the Danish Realm, and antineoplastic treat-
ment is provided in close collaboration with Danish hospitals. As of 
2004, chemotherapy for breast, lung, pancreatic and gastrointestinal 
cancer was treated in collaboration with oncologists at Rigshospitalet 
and is administered at Queen Ingrid’s Hospital (QIH) in Nuuk (Gelvan, 
Risum, & Langer, 2015). Patients living outside Nuuk usually have to 
travel long distances for antineoplastic treatment and may be sep-
arated from their families for long periods, which may reduce their 
quality of life. In addition, patients and their families in remote areas 
can have a wide range of unmet needs including access to services, 
information, practical help and medical support (White et al., 2011).
Specialist palliative care is not yet available in Greenland but is 
being planned, and knowledge about the needs of patients with ad-
vanced cancer and their relatives is of high priority (Departementet 
for Sundhed D, 2015). Studies on illness development and health- 
related quality of life (HRQoL) are important to identify current 
needs and to promote a clinical and research agenda in Greenland. 
Furthermore, assessment of symptoms and health- related quality 
of life is useful in measuring the effectiveness of future interven-
tions for patients with advanced cancer (Lavergne, Johnston, Gao, 
Dummer, & Rheaume, 2011; Reeve et al., 2013).
Structured use of assessment tools aims at providing symptom 
relief, but can also enhance research, education and public aware-
ness of palliative care (Strömgren, Goldschmidt, et al., 2002). The 
Greenlandic version of the EORTC QLQ- C30 has recently been trans-
lated and partly validated in a cross- sectional study. The Greenlandic 
version of the EORTC QLQ- C30 proved to be an applicable and reli-
able tool. The study demonstrated that patients with advanced can-
cer reported high levels of social and financial problems and reduced 
physical functioning. The study indicated a potential for establishing 
palliative care service in Greenland (Augustussen, Sjøgren, Timm, 
Hounsgaard, & Pedersen, 2017).
The aim of this prospective study was to assess the develop-
ment of symptoms and HRQoL in patients with advanced cancer in 
Greenland.
2  | METHODS
2.1 | Study design and recruitment of participants
From June 2015 to March 2016, a prospective observational study 
was undertaken in a population of patients with advanced cancer in 
Greenland.
Recruitment of patients was based on the electronic medical 
records (EMR) by extracting cancer diagnoses according to ICD- 10 
DC00- DD48 codes. The EMR for patients with a registered cancer 
diagnosis, who had been in contact with the healthcare system, was 
assessed to identify eligible patients with advanced cancer.
All eligible patients were contacted by telephone and provided 
with information about the purpose of the study. Patients were in-
cluded consecutively during the observation period of 4 months.
2.2 | Inclusion and exclusion criteria
Inclusion criteria were patients aged 18 years and over, with per-
manent address in Greenland and in treatment for advanced cancer 
disease with non- curative or no antineoplastic treatment options. 
Exclusion criteria were information in the EMR about cognitive im-
pairment or inability to answer questionnaires.
2.3 | Setting and data collection
The healthcare system is organised in five healthcare regions, with 
QIH in Nuuk functioning as the central hospital. Chemotherapy is 
given according to Danish guidelines in an outpatient clinic in the de-
partment of internal medicine at QIH (Gelvan et al., 2015). Patients 
from other villages and settlements are transferred for treatment by 
helicopter, boat, plane or ship. Healthcare services including medi-
cation, hospital treatment and transportation to hospital are free of 
costs for permanent inhabitants in Greenland. Some patients receive 
oncological treatment at a Danish hospital after assessment and re-
ferral from a physician.
Data collection was primarily through structured telephone 
interviews, supplemented with face- to- face interviews in Nuuk if 
patients were available and/or preferred this contact form. Each pa-
tient completed the EORTC QLQ- C30 questionnaire at baseline and 
then once a month for 4 months.
2.4 | Assessment
HRQoL refers to different aspects of quality of life (physical, emo-
tional, social and role functioning and general well- being), and the 
EORTC questionnaires have been translated and validated in over 
100 languages worldwide and used in more than 3,000 studies 
(European Organisation for Research and Treatment of cancer 
webpage). The EORTC QLQ- C30 core version 3.0 is a cancer- 
specific and multidimensional questionnaire designed to explore 
different aspects of functionality, symptomatology and HRQoL 
(Wintner et al., 2016). The Greenlandic version was recently 
validated and showed acceptable internal consistency in the as-
sessment of symptoms and HRQoL among Greenlandic patients 
with advanced cancer (Augustussen et al., 2017). The validated 
Danish version of the EORTC QLQ- C30 was completed by Danish- 
speaking patients (Strömgren, Groenvold, Pedersen, Olsen, & 
Sjogren, 2002)).
The EORTC QLQ- C30 consists of five function scales (physi-
cal, role, cognitive, emotional and social), three symptom scales 
(fatigue, pain and nausea/vomiting), a global health status scale 
and six single items (dyspnoea, loss of appetite, insomnia, con-
stipation, diarrhoea and financial problems). According to the 
scoring manual, each item score is transformed into a 0–100 
scale (Fayers et al., 2001). Scoring on the single items is thus 
0 (Not at all), 33.3 (A little), 66.7 (Quite a bit) and 100 (Very 
much). Higher scores on the functioning scale reflect better 
functioning, while higher scores on the symptom scales and 
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single items reflect a high level of symptoms (Fayers & 
Bottomley, 2002).
Inspired by King (1996) we considered a difference in scores of 
10 clinically significant for the EORTC QLQ- C30 scales.
Although no official definition of poverty exists in Greenland, 
patients with self- reported annual income below 14,805 US dollars 
were categorised as poor, in line with the official Danish poverty line 
(Schnohr, Nielsen, & Wulff, 2007).
2.5 | Statistics
Variables were dichotomised in the statistical analysis and described using 
means and standard deviation (SD). Mean differences in scores were cal-
culated by subtracting scores from baseline (T1–T0, T2–T0 and T3–T0). 
Comparisons between groups (lung cancer vs. non- lung cancer, lower in-
come vs. higher income, Nuuk citizens vs. non- Nuuk citizens) were made 
using Wilcoxon’s rank test. A p- value below .05 was used as level of sig-
nificance. SAS version 9.4 was used for all statistical calculations.
2.6 | Ethics
The project was assessed according to the Helsinki declaration 
and was approved by the Ethics Committee for Medical Research 
in Greenland (2014- 102760) and the Data Protection Agency in 
Denmark (2014- 41- 3660). Permission to review data from the 
EMR was given by data owner Agency of Health and Prevention in 
Greenland. Informed consent was obtained after giving all partici-
pants a thorough written and oral presentation of the study. They 
were informed that participation was voluntary and that they could 




A total of 664 patients with a cancer diagnosis were identified 
through the EMR system. During the inclusion period from June 
2015 to March 2016, 82 patients were found eligible. Six of them 
died before contact, nine declined to participate, and nine did not 
respond to phone calls. Reasons for declining were that patients did 
not have time and/or energy to participate.
Figure 1 illustrates participating patients and dropouts. In total, 
58 patients completed the questionnaire at baseline and were in-
cluded in the study, giving a response rate of 71% (58/82).
Of the 58 patients, 27 (47%) completed the full observation 
period, 12 patients died, 16 dropped out and three were excluded 
(Figure 1). Reasons for dropping out were that patients did not have 
time and/or energy. The reasons for exclusion in three patients were 
that palliative care shifted to curative intentional treatment or cog-
nitively impairment.
Patients’ characteristics at baseline are shown in Table 1. Mean 
age for men was significantly higher (62 years) than for women 
(56 years; p = .013), one- third of patients had elementary school as 
highest education, and half of the patients had an income below the 
Danish poverty line. Lung cancer (45%) was the most common can-
cer diagnosis.
3.2 | Functional and symptom scores
A general overview of mean scores, regardless of characteristics, 
for the four observation points is provided in Table 2. All functional 
scores were generally high throughout the observation period. The 
highest symptom score was noted for fatigue, followed by pain and 
financial problems.
Table 3 shows changes in mean scores at four observation points 
and the statistically significant differences. Statistically significant 
improvement in social functioning was seen after 1 month (p = .009) 
and 2 months (p = .0012) respectively. A statistically significant de-
cline in Global Health was observed at 1 month, although the clinical 
relevance appeared to be marginal due to a reduction of 8 in the 
mean score (p = .009).
F IGURE  1 Flow diagram illustrating participating patients and 
dropout
Baseline
n = 58 patients (T0)
47 patients after 1 month
37 patients after 2 months
27 patients afte r3 months
5 died: 4 stopped: 1 excluded
4 died: 6 stopped
3 died:6 stopped, 2 
exluded
4 of 7  |     AUGUSTUSSEN ET Al.
3.3 | The impact of cohabitating status, income, 
diagnosis and residence
Cohabiting patients reported significantly more insomnia than did 
patients living alone at 2 months (p = .04) and 3 months (p = .01). 
Furthermore, emotional functioning at 3 months for patients living 
alone had improved significantly more than for cohabitating patients 
(p = .04).
At 3 months, patients with higher income had significantly re-
duced pain intensity (p = .03) and diarrhoea (p = .05) than patients 
with income under the poverty line.
Compared to non- lung cancer patients, those with lung can-
cer had significant improvement in social functioning at 2 months 
(p = .0015).
At 1 month, significant reduction in pain intensity was observed 
for Nuuk citizens compared with non- Nuuk citizens (p = .05). At 
2 months, non- Nuuk citizens reported significantly improved social 
functioning compared with Nuuk citizens (p = .05). At 3 months, 
Global Health in Nuuk citizens was improved compared with that of 
non- Nuuk citizens (p = .05).
4  | DISCUSSION
This prospective longitudinal study took place in a unique geograph-
ical environment, where palliative care in both the main hospital 
and the community (primary and secondary palliative care) is at a 
basic level, and specialised palliative care is not yet established. It is 
one of the first studies to assess the physical, emotional, social and 
cognitive problems in patients with advanced cancer in Greenland 
(Augustussen et al., 2017). Assessment of symptoms in Greenlandic 
patients with advanced cancer will hopefully not only provide a basis 
for future planning, but also enhance the focus of healthcare profes-
sionals working in the Greenlandic healthcare system on the bene-
fits of systematic assessment (Homsi et al., 2006). The current study 
was based on consecutive patients referred to QIH and, although 
TABLE  2 Overview of mean scores from baseline to the third month
Baseline mean  
(SD) n = 58
After 1 month  
 (SD) n = 47
After 2 months  
 (SD) n = 37
After 3 months  
 (SD) n = 27
Functional scales
Physical functioning 69 (22) 64 (24) 63 (24) 62 (23)
Role functioning 63 (31) 53 (31) 59 (32) 50 (32)
Emotional functioning 77 (21) 76 (23) 79 (24) 81 (17)
Cognitive functioning 76 (24) 81 (22) 75 (24) 72 (28)
Social functioning 55 (35) 66 (31) 68 (29) 62 (37)
Global health status/QoL 66 (23) 59 (23) 70 (22) 61 (24)
Symptom scales
Fatigue 39 (27) 41 (27) 37 (32) 44 (29)
Nausea/vomiting 11 (15) 17 (27) 14 (18) 18 (25)
Pain 31 (27) 28 (32) 36 (38) 37 (34)
Single items
Dyspnoea 25 (33) 32 (36) 29 (30) 39 (39)
Insomnia 28 (31) 30 (34) 27 (36) 28 (34)
Appetite loss 24 (31) 24 (29) 27 (38) 38 (40)
Constipation 21 (32) 25 (32) 21 (36) 32 (36)
Diarrhoea 19 (28) 15 (25) 15 (25) 13 (23)
Financial problems 33 (41) 37 (41) 35 (40) 33 (45)
Characteristics All N = 58 Male N = 37 Female N = 21
Mean age (SD) 59 62 (9) 56 (8)
Single living, n (%) 23 (39) 13 (35) 10 (47)
Lung cancer, n (%) 26 (45) 20 (54) 6 (29)
Low income < 14.980 USD 30 (51) 17 (46) 13 (62)
Nuuk resident, n (%) 14 (24) 7 (19) 7 (33)
No education/elementary 
school, n (%)
20 (34) 10 (27) 10 (47)
TABLE  1 Basic characteristics of 
participants with advanced cancer
     |  5 of 7AUGUSTUSSEN ET Al.
the sample size is small, it represents the first attempt to assess the 
developments HRQoL and symptoms in a Greenlandic population of 
patients with advanced cancer.
Compared to Danish patients with advanced cancer in special-
ised palliative care, the Greenlandic patients had higher scores on all 
functional scales throughout the period (Strömgren et al., 2005). The 
mean scores at baseline for the Danish palliative population were as 
follows: physical 30, role 14.5, emotional 55.9, cognitive 50.7 and 
social 46.6, whereas the corresponding figures for Greenlandic pop-
ulation were 69, 63, 77, 76 and 55 for social functioning. Thus, the 
functional scores in patients with advanced cancer in Greenland are 
considerably higher, which may involve selection of patients during 
the disease trajectory in Denmark and Greenland due to different 
living conditions and healthcare systems. Regarding the latter espe-
cially availability and accessibility of treatment and care, which for 
the Greenlanders may involve long travel distances—particularly, 
for those residents outside Nuuk. Although the Danish study is now 
12 years old, these findings are extremely interesting and worth-
while investigating more details in future studies.
The most striking finding was that financial problems, which may 
be associated with the lower scores on social functioning, persisted 
throughout the study period, indicating that most patients had eco-
nomic difficulties. The observed differences between Greenlandic 
and Danish patients may be partly explained by pronounced income 
differences between the two countries. The average personal in-
come in Greenland is 32.948 USD (Statistics Greenland, 2016) while 
that in Denmark is 45.089 USD (Danmarks Statistik, 2016). Further, 
a recent survey showed that inhabitants of settlements and smaller 
cities were less educated than those living in Nuuk and were more 
likely to supplement their income with hunting and fishing (Petersen 
& Bjerregaard, 2014). This supplement may be harder to achieve 
when a family member has advanced cancer and has to travel to 
treatment every 3 weeks. Fatigue was the most frequently reported 
symptom followed by pain, as demonstrated in other prospective 
studies (Färkkilä et al., 2014; Homsi et al., 2006; Strömgren et al., 
2006).
As expected, patient attrition was high, and only 47% of patients 
completed the 4- month study period. Previous longitudinal studies 
in patients with advanced cancer have reported substantial prob-
lems due to attrition (Strömgren et al., 2005). In our study, 11 pa-
tients dropped out at the start and then approximately 10 per month 
in the rest of the observation period. The main reasons for drop-
ping out were insufficient time or energy. Some patients felt that 
the questionnaire completion was too time- consuming for them and 
that it had no impact on clinical practice.
Previous studies in similar populations have shown that patients 
not participating in a study were more frail, older and had shorter 
survival than participants (Ahlner- Elmqvist, Bjordal, Jordhøy, Kaasa, 
& Jannert, 2009; Strömgren, Goldschmidt et al., 2002). It was con-
cluded that non- participants had more advanced- stage disease and 
more pronounced symptomatology. Thus, the current study may 
have some selection bias resulting in underestimation of symptom-
atology and overestimation of functional capacity and HRQoL.
The small sample size (reflecting the small number of patients 
with advanced cancer in Greenland) limited statistical analysis, es-
pecially regarding predictor and subgroup analysis that could have 
contributed with more information for major subgroups of patients. 
With these precautions in mind, between- group comparisons can 
still illustrate possible trends, however. We found that patients living 







Physical functioning −4 .4404 −5 .3444 −4 .3014
Role functioning −7 .0866 2 .7968 −2 .8944
Emotional 
functioning
0 .7287 3 .8032 5 .1863
Cognitive 
functioning
2 .5239 −2 .8133 −5 .5523
Social functioning 10 .009* 13 .0012* 9 .1001
Global health status/
QoL
−8 .009* 3 .3734 −6 .1989
Fatigue 4 .1065 1 .8754 8 .1806
Nausea/vomiting 6 .1048 3 .3929 8 .1191
Pain −4 .3954 5 .1910 3 .7008
Dyspnoea 5 .3364 0 .9496 5 .6773
Insomnia −1 .9506 −2 .7917 −1 1
Appetite loss 1 .8539 5 .3879 12 .0979
Constipation 4 .3232 1 .7693 10 .2676
Diarrhoea 3 .4366 2 .6914 0 1
Financial problems 3 .7328 0 .9608 −6 .5664
Statistically significant p- value marked with*.
TABLE  3 Changes in mean scores for 
all patients from baseline to T1, T2 and T3
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cohabitating patients. A Danish study similarly found that patients 
living alone achieved more symptom relief than did cohabitating pa-
tients (Strömgren et al., 2005). However, in a Greenlandic setting, 
our findings may be explained by the patients living alone receiving 
more public assistance and attention, as the assessment of needs for 
assistance is mainly based on social living situation (The Government 
of Greenland, 2006).
In a healthcare system with limited resources, a part of the ev-
eryday life is to prioritise between the patients who are referred. 
The capacity of specialised palliative care in Denmark is substan-
tially lower than that recommended by the EAPC (Radbruch & 
Payne, 2009), and as mentioned earlier specialised palliative care is 
not available in Greenland. The late introduction of palliative care 
and the low public awareness of palliative care in Denmark may have 
affected the situation in Greenland (Hoefler & Vejlgaard, 2011). The 
finding that higher- income patients had significant reduction in pain 
intensity and diarrhoea compared with patients under the poverty 
line may be indirectly due to well- known inequality of access to 
health care associated with socio- economic factors (Dixit, Crawford, 
Lemonde, Rittenberg, & Ortega, 2016). The relatively limited access 
and availability of health care in general, and palliative care in par-
ticular, may have important consequences for certain subgroups, for 
example individuals with lower income.
Our observation that lung cancer patients showed significant 
improvement in social functioning during the observation period 
compared with non- lung cancer patients is not readily explainable. It 
is possibly due to greater focus from the healthcare system on this 
major diagnosis, which is often associated with poor prognosis, a 
heavy symptom burden and emotional distress (Morrison et al., 2017).
Finally, we found that during the observation period non- Nuuk 
residents reported worse pain and HRQol than Nuuk citizens, which 
might be explained by limited access to QIH and/or the strenuous 
travelling for treatments and separation from relatives. At 2 months, 
however, non- Nuuk citizens had improved social functioning com-
pared with Nuuk citizens.
Provision of palliative care in remote areas faces geographical 
and logistic challenges (Dewar et al., 2003; Duggleby et al., 2011; 
White et al., 2011). Healthcare services in Greenland provide pri-
mary care (delivered by generalists such as general practitioners, 
family physicians and general internists) and secondary care (by 
oncologists) for the treatment of cancer, but not tertiary pallia-
tive care (by specialist palliative care physicians). This approach 
is based on the concept that most palliative care can (and should) 
be provided by generalists, with oncologists managing specific 
issues, and palliative care specialists providing consultation for 
complex problems (Ferris et al., 2009). Thus, educational initia-
tives and a higher degree of integration between primary and 
secondary levels may be a way to strengthen palliative care in 
Greenland. According to the EAPC white paper, however, a pal-
liative care specialist team situated at QIH could be justified 
on the basis of Greenland’s population size (Radbruch & Payne, 
2009). The geographical challenges mean that telehealth services 
could be appropriate to provide cancer care in remote places, 
as described in several studies conducted in rural and remote 
areas (Donnem et al., 2012; Hebert, 2007; Laila, Rialle, Nicolas, 
Duguay, & Franco, 2008). Finally, clinical implementation of sys-
tematic symptom management seems to be highly warranted in 
the Greenlandic population of patients with advanced cancer 
(Augustussen et al., 2017).
5  | CONCLUSION
This prospective observational study shows improvement on social 
functioning and decline in Global Health in patients with advanced 
cancer. An important clinical finding is that patients’ needs for support 
are related to social income, and geographical factors should be taken 
into account in symptom management. High economic problems were 
reported during the entire period. Even though all patients needed 
support and symptom management, it is noteworthy that non- Nuuk 
resident seemed to have heavier symptom burden. This is an important 
clinical finding and shows that patients’ needs for support are related to 
social income and attention is needed on geographical factors.
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